Industry News
Pharmaceutical Industry News
The industry is entering “the…
The industry is entering “the golden era for biosimilars,” Amneal co-CEO Chirag Patel said Wednesday morning as he explained the motivation for his company’s $1.1 billion acquisition of Kashiv BioSciences.
As Samsung Biologics presented a…
As Samsung Biologics presented a massive quarterly revenue growth, 2,200 people rallied ahead of a planned labor union strike.
Amid industry layoffs and M&A…
Amid industry layoffs and M&A headlines, Big Pharma's embrace of AI is gaining more steam.
4 Medications That May Increase Dementia Risk
Experts have flagged several over-the-counter and prescription medications.
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.
Novartis is running a new disease…
Novartis is running a new disease awareness campaign for Sjögren's syndrome with help from dancer, choreographer, and TV personality Carrie Ann Inaba.
UnitedHealth Group Reports Flat Earnings in the First Quarter
The nation’s largest insurer’s profits exceeded analysts’ expectations but still fell short of showing a significant comeback.
Astellas R&D leaders, Jotaro…
Astellas R&D leaders, Jotaro Suzuki, Marci English, and Erin Kimbrel, reflect on how cell therapy could change the future of degenerative diseases.
The once-daily HIV treatment…
The once-daily HIV treatment regimen offers a new mechanism of action in the HIV treatment market.
Pfizer’s chief strategy and…
Pfizer's chief strategy and innovation officer Andrew Baum is stepping down merely two years into the role, according to reports.
Fierce Pharma is launching the…
Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts’ notes and IQVIA data to monitor prescription trends and shifting market shares as Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo vie to become
In a phase 3 trial in the rare…
In a phase 3 trial in the rare kidney disease IgAN, AstraZeneca said its Ultomiris delivered a clinically meaningful and statistically significant reduction in protein from the urine after 34 weeks.
After prevailing in two kidney…
After prevailing in two kidney cancer trials in the refractory and early-stage settings, Merck & Co.’s blockbuster prospect Welireg surprisingly failed to ignite hope as a first-line treatment.
UCB is teaming up with the…
UCB is teaming up with the Myasthenia Gravis Foundation of America and Factor Meals to provide premade meals to 250 families affected by myasthenia gravis, a chronic disease that can cause muscle weakness, fatigue and
Sanofi’s protein-based vaccine…
Sanofi’s protein-based vaccine Nuvaxovid has topped Moderna’s next-generation messenger RNA shot mNexspike in a head-to-head trial assessing the tolerability of the two COVID vaccines.
Genentech has launched the “Life…
Genentech has launched the “Life Doesn’t Wait” campaign to mark World Hemophilia Day, dialing up its focus on patient stories ahead of the expected intensification of competition in the hemophilia A market.
Neurogene is looking to make the…
Neurogene is looking to make the leap from a clinical biotech to a commercial biopharma with its lead gene therapy and has hired an industry veteran to take the reins.
Biovac has secured a $108.3…
Biovac has secured a $108.3 million financing package that will allow the South African pharma company to build the continent’s first end-to-end, multi-vaccine production plant.
Theramex has opted out of the…
Theramex has opted out of the U.K.’s self-regulatory program for pharma marketing after being found to have brought discredit on the industry twice in quick succession.
In a blow to Bayer, a U.S. federal…
In a blow to Bayer, a U.S. federal judge in Manhattan has said he will not block Johnson & Johnson’s survival claims on a key prostate cancer drug.